Abstract:Acute myocardial infarction (AMI) continues as the main cause of morbidity and mortality worldwide. Interestingly, emerging evidence highlights the role of gut microbiota in regulating the pathogenesis of coronary heart disease, but few studies have systematically assessed the alterations and influence of gut microbiota in AMI patients. As one approach to address this deficiency, in this study the composition of fecal microflora was determined from Chinese AMI patients and links between gut microflora and clinical features and functional pathways of AMI were assessed. Fecal samples from 30 AMI patients and 30 healthy controls were collected to identify the gut microbiota composition and the alterations using bacterial 16S rRNA gene sequencing. We found that gut microflora in AMI patients contained a lower abundance of the phylum Firmicutes and a slightly higher abundance of the phylum Bacteroidetes compared to the healthy controls. Chao1 ( P = 0.0472) and PD-whole-tree ( P = 0.0426) indices were significantly lower in the AMI versus control group. The AMI group was characterized by higher levels of the genera Megasphaera , Butyricimonas , Acidaminococcus , and Desulfovibrio , and lower levels of Tyzzerella 3 , Dialister , [Eubacterium] ventriosum group , Pseudobutyrivibrio , and Lachnospiraceae ND3007 group as compared to that in the healthy controls ( P < 0.05). The common metabolites of these genera are mostly short-chain fatty acids, which reveals that the gut flora is most likely to affect the occurrence and development of AMI through the short-chain fatty acid pathway. In addition, our results provide the first evidence revealing remarkable differences in fecal microflora among subgroups of AMI patients, including the STEMI vs. NSTEMI, IRA-LAD vs. IRA-Non-LAD and Multiple (≥2 coronary stenosis) vs. Single coronary stenosis groups. Several gut microflora were also correlated with clinically significant characteristics of AMI patients, including LVEDD, LVEF, serum TnI and NT-proBNP, Syntax score, counts of leukocytes, neutrophils and monocytes, and fasting serum glucose levels. Taken together, the data generated enables the prediction of several functional pathways as based on the fecal microfloral composition of AMI patients. Such information may enhance our comprehension of AMI pathogenesis.

Gut microbiota alterations after acute coronary syndrome: a single center, case-control pilot study

Alterations of gut microbiome profiles as potential markers in patients developing acute coronary syndrome

Characteristics, prognostic determinants of monocytes, macrophages and T cells in acute coronary syndrome: protocol for a multicenter, prospective cohort study

Insights from metagenomics into gut microbiome associated with acute coronary syndrome therapy

Dysbiosis of Gut Microbiota in Patients With Acute Myocardial Infarction

Gut Microbiota Community Shift with Severity of Coronary Artery Disease

Analysis of gut microbiota in patients with acute myocardial infarction by 16S rRNA sequencing

One-year longitudinal changes of peripheral CD4+ T-lymphocyte counts, gut microbiome, and plaque vulnerability after an acute coronary syndrome

The Changes of Gut Microbiota after Acute Myocardial Infarction in Rats

Alterations in the Gut Microbiome and Metabolism with Coronary Artery Disease Severity.

Gut Lactobacillus Level Is a Predictive Marker for Coronary Atherosclerotic Lesions Progress and Prognosis in Patients With Acute Coronary Syndrome

Gut microbiome-based noninvasive diagnostic model to predict acute coronary syndromes

Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality.

Gut microbiota combined with metabolites reveals unique features of acute myocardial infarction patients different from stable coronary artery disease

The Microbial and Metabolic Signatures of Patients with Stable Coronary Artery Disease.

The gut microbiome and microbial metabolites in acute myocardial infarction

Association Study of Gut Flora in Coronary Heart Disease Through High-Throughput Sequencing

Characterization of gut microbiota in adults with coronary atherosclerosis

Changes of the gut microbiota composition and short chain fatty acid in patients with atrial fibrillation

Roles of oral and gut microbiota in acute myocardial infarction

Gut microbial signatures in clinically stable ulcerative colitis according to the mucosal state and associated symptoms